<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04329338</url>
  </required_header>
  <id_info>
    <org_study_id>NAUTH/CS/66/V046</org_study_id>
    <nct_id>NCT04329338</nct_id>
  </id_info>
  <brief_title>Effects of Lactobacillus Pentosus KCA1 on the Gut and Vaginal Microbiome of Women With Bacterial Vaginosis</brief_title>
  <official_title>Effects of Lactobacillus Pentosus KCA1 on the Gut and Vaginal Microbiome of Women With Bacterial Vaginosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nnamdi Azikiwe University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nnamdi Azikiwe University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bacterial vaginosis (BV) is under-reported, misdiagnosed and inappropriately treated in
      Nigeria. Treatment option rely on antibiotics that eliminates both good and pathogenic
      bacteria, with gross impact on the gut and vaginal microbiome. Our primary objective in this
      study is to determine the effects of Lactobacillus on the gut and vagina when taken orally.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Antibiotics reduces in considerable proportion both the healthy bacteria especially
      Lactobacilli and those associated with BV, thus the vaginal microecology and gut is adversely
      affected. It is widely acknowledged that Lactobacilli and other genera that produces some
      metabolites such as lactic acid, contributes to vaginal health by maintaining the low pH of
      the vagina.

      The objectives of this study are three folds, first to determine the effects before and after
      14 days oral feeding of Lactobacillus pentosus KCA1 on the vaginal and gut microbiota
      compositions of women diagnosed with BV. Second to measure the level of two proinflammatory
      cytokines IL-1 beta and IL-6 before and after KCA1 consumption and third to determine in
      silico, the relative abundance of microbial genes involved in metabolic functions using the
      16S rRNA datasets.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 8, 2017</start_date>
  <completion_date type="Actual">December 10, 2019</completion_date>
  <primary_completion_date type="Actual">September 20, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>In this case each participant served as control as we collected sample before and after intervention</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>This is an open label study</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Nugent score</measure>
    <time_frame>14 days</time_frame>
    <description>Gram stain microscopy for different bacterial morphotypes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gut and Vaginal microbiota</measure>
    <time_frame>14 days</time_frame>
    <description>Relative abundance of bacterial communities before and after Lactobacillus pentosus KCA1</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>IL-6 Proinflammatory cytokine</measure>
    <time_frame>14 days</time_frame>
    <description>Levels of Interleukin-6 with Enzyme-Linked Immunosorbent assay (ELISA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IL-1beta Proinflammatory cytokine</measure>
    <time_frame>14 days</time_frame>
    <description>Level of Interleukin-I beta with Enzyme-Linked Immunosorbent assay (ELISA)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">7</enrollment>
  <condition>Bacterial Vaginoses</condition>
  <arm_group>
    <arm_group_label>Gut and vaginal sample collection</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Gut and vaginal samples were collected for Nugent score, and 16S rRNA metagenomics communities.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Gut and Vaginal sample after Lactobacillus</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Seven women diagnosed with BV by Nugent score (7-10) provided vaginal and gut sample after 14 days oral intake of 3 grams (2.5X108 cfu/g) of Lactobacillus pentosus KCA1</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lactobacillus pentosus KCA1</intervention_name>
    <description>Lactobacillus pentosus KCA1 suspended in dairy and taken orally for 14 days</description>
    <arm_group_label>Gut and Vaginal sample after Lactobacillus</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Not on antibiotic therapy within the last one month

          -  Not menstruating at the time of inclusion.

        Exclusion Criteria:

        Pregnant, use of antibiotic medication, declined informed consent, menstruating and those
        that used douches, sprays, spermicides in the last 48 hours

        -
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Nnamdi Azikiwe University Teaching Hospital</name>
      <address>
        <city>Nnewi</city>
        <state>Anambra</state>
        <country>Nigeria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Nigeria</country>
  </location_countries>
  <reference>
    <citation>Anukam KC, Macklaim JM, Gloor GB, Reid G, Boekhorst J, Renckens B, van Hijum SA, Siezen RJ. Genome sequence of Lactobacillus pentosus KCA1: vaginal isolate from a healthy premenopausal woman. PLoS One. 2013;8(3):e59239. doi: 10.1371/journal.pone.0059239. Epub 2013 Mar 19.</citation>
    <PMID>23527145</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 27, 2020</study_first_submitted>
  <study_first_submitted_qc>March 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2020</study_first_posted>
  <last_update_submitted>March 31, 2020</last_update_submitted>
  <last_update_submitted_qc>March 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nnamdi Azikiwe University</investigator_affiliation>
    <investigator_full_name>Kingsley C Anukam</investigator_full_name>
    <investigator_title>Reader/Research Scientist</investigator_title>
  </responsible_party>
  <keyword>Lactobacillus</keyword>
  <keyword>Microbiota</keyword>
  <keyword>Nigerian women</keyword>
  <keyword>Gut</keyword>
  <keyword>Vagina</keyword>
  <keyword>16S rRNA</keyword>
  <keyword>Sequencing</keyword>
  <keyword>Metagenomics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaginosis, Bacterial</mesh_term>
    <mesh_term>Vaginal Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

